Safety and early biologic effects of phase 1 PERIO-01 trial of pressure-enabled drug delivery (PEDD) of TLR9 agonist SD-101 and immune checkpoint inhibition (ICI) in uveal melanoma metastatic to the liver (MUM).

Authors

Kamaneh Montazeri

Massachusetts General Hospital, Boston, MA

Kamaneh Montazeri , Diwakar Davar , Cara L. Haymaker , Rahul Sheth , Joshua Kuban , Joshua Weintraub , Eric Wehrenberg-Klee , Paula M. Novelli , Carin F. Gonsalves , Robert D. Adamo , Anthony Lucci , Salyna Meas , Vanessa Nicole Sarli , Victor Gerardo Prieto , David A. Geller , Marlana M. Orloff , Richard D. Carvajal , Sapna Pradyuman Patel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Clinical Trial Registration Number

NCT04935229

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 2521)

DOI

10.1200/JCO.2023.41.16_suppl.2521

Abstract #

2521

Poster Bd #

363

Abstract Disclosures

FEATURED

Safety and early biologic effects of phase 1 PERIO-01 trial of pressure-enabled drug delivery (PEDD) of TLR9 agonist SD-101 and immune checkpoint inhibition (ICI) in uveal melanoma metastatic to the liver (MUM).

Authors

Kamaneh Montazeri

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Poster Details

Meeting

Session Type

Session Title

Track

Sub Track

Clinical Trial Registration Number

Citation

DOI

Abstract #

Poster Bd #

Similar Posters

Poster

Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with ipilimumab and nivolumab, in patients with neuroendocrine carcinoma.

Poster

Immune infiltrates in metastatic uveal melanoma liver metastases and associations with clinical outcomes.

Poster

A phase I, randomized, controlled, multicentre trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM 2 trial).

Poster

Safety and efficacy of immune checkpoint inhibitors (ICI) in advanced penile squamous cell carcinoma (PeCa): An international study from the Global Society of Rare Genitourinary Tumors (GSRGT).